Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

Sanofi is now in “exclusive ... Opella is a leading supplier of over-the-counter medicines, vitamins, minerals and supplements. Some of its most popular products include the antihistamine ...

Sanofi said it is the third-largest business worldwide in the market for over-the-counter medicines ... production volume for Opella's sensitive products in France," Armand added, including ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

With its decision, Sanofi joined peers Johnson & Johnson, Pfizer and GSK in hiving off businesses that sell over-the-counter medicines ... sell different types of products and services to both ...

including details by product and quarter, are expected to be provided in the coming weeks. After the closing of the transaction, the share of results from the retained minority interest in Opella will ...

which is the third-largest business in the world in the over-the-counter and vitamins, minerals & supplements market, according to Sanofi. The French pharma company said the deal, which saw CD&R ...

The French government has warned the United States investment company buying the consumer healthcare division of drugmaker ...

Sanofi said it is the third-largest business worldwide in the market for over-the-counter medicines ... production volume for Opella's sensitive products in France," Armand added, including ...